Nautilus Biotechnology, Inc. NAUT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -5.64% | -12.19% | -18.28% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -6.69% | -14.43% | -22.80% | -18.99% |
| Operating Income | -- | 7.80% | 14.43% | 22.80% | 18.99% |
| Income Before Tax | -- | 3.75% | 11.53% | 21.67% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | 3.75% | 11.53% | 21.67% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 3.75% | 11.53% | 21.67% | 17.46% |
| EBIT | -- | 7.80% | 14.43% | 22.80% | 18.99% |
| EBITDA | -- | 6.91% | 14.09% | 22.84% | 19.04% |
| EPS Basic | -14.33% | 4.45% | 11.85% | 22.02% | 18.00% |
| Normalized Basic EPS | -14.29% | 4.44% | 11.91% | 23.98% | 17.95% |
| EPS Diluted | -14.33% | 4.45% | 11.85% | 22.02% | 18.00% |
| Normalized Diluted EPS | -14.29% | 4.44% | 11.91% | 23.98% | 17.95% |
| Average Basic Shares Outstanding | 0.74% | 0.74% | 0.39% | 0.46% | 0.68% |
| Average Diluted Shares Outstanding | 0.74% | 0.74% | 0.39% | 0.46% | 0.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |